Dow Down 1.29% Nasdaq Down 3.25%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.07 Down 0.27(5.06%) Feb 5, 4:00PM EST
|After Hours : 5.07 0.00 (0.00%) Feb 5, 4:57PM EST
Prev Close:5.34
Open:5.30
Bid:4.79 x 300
Ask:5.62 x 400
1y Target Est:7.88
Beta:1.64489
Next Earnings Date:23-Feb-16ARIA Earnings announcement
Day's Range:5.06 - 5.30
52wk Range:4.72 - 10.07
Volume:3,654,117
Avg Vol (3m):3,426,840
Market Cap:959.72M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 5.06%959.72M
PFEUp 0.10%179.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.24
Quarterly EPS Est (Dec-15) :-0.31
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback